[Treatment of immune thrombocytopenia: a retrospective study of 40 patients]

Clicks: 255
ID: 270656
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
ITP is a rare disorder occurring most frequently in middle aged patients. Because of high relapse or no response rates, many treatments should be used. Dapsone offers a good efficacy without major side effects. RTX is well tolerated and allows a good response rate. The use of new agents like thrombo …
Reference Key
s2010la[treatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Audia S;Lakomy D;Guy J;Leguy-Seguin V;Berthier S;Aho S;Lorcerie B;Bonnotte B;;
Journal la revue de medecine interne
Year 2010
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/20409619
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult female male aged middle aged English Abstract Antibodies Monoclonal Retrospective Studies monoclonal / therapeutic use anti-infective agents / therapeutic use drug therapy combination immunologic factors / therapeutic use glucocorticoids / therapeutic use rituximab splenectomy pmid:20409619 doi:10.1016/j.revmed.2009.11.008 s audia d lakomy b bonnotte murine-derived dapsone / therapeutic use purpura thrombocytopenic idiopathic / diagnosis idiopathic / drug therapy idiopathic / surgery idiopathic / therapy*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.